Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

U.S. drug developer Capricor places Duchenne drug trial on hold

December 26, 2018 1:57 PM
104 0

(Reuters) - Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy (DMD), a muscle-wasting disorder, citing a safety review.

The review follows a severe allergic reaction during infusion of the drug, the company said in a filing here. The patient responded well to medical treatment and is currently asymptomatic.

Read more

Share in social networks:

Comments - 0